Comparison of pulmonary arterial risk assessment tools to predict mortality or morbidity in treatment naive and previously diagnosed patients.

Back

ESC Premium Access

Comparison of pulmonary arterial risk assessment tools to predict mortality or morbidity in treatment naive and previously diagnosed patients.

Session: Impact of pulmonary hypertension on quality of life and survival

Topic: Pulmonary Hypertension

Speaker: Doctor C. Fauvel (Rouen, FR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Charles Fauvel

University Hospital of Rouen, Rouen (France)

2 presentations

0 follower

7 more presentations in this session

Prognostic value of follow-up hemodynamics after initial treatment in pulmonary arterial hypertension

Speaker: Doctor D. Guarino (Bologna, IT)

Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry

Speaker: Professor C. Kaymaz (Istanbul, TR)

Acute vasoreactivity testing for severe pulmonary hypertension associated with lung disease

Speaker: Doctor R. Takano (Suita, JP)

Health care utilisation in patients with mild pulmonary hypertension - EVIDENCE-PAH UK study

Speaker: Doctor N. Karia (London, GB)

Does the presence of severe pulmonary hypertension affect survival at 5 years follow-up in patients who underwent TAVI for severe aortic stenosis?

Speaker: Doctor H. Mohiaddin (Leicester, GB)

Access the full session

Impact of pulmonary hypertension on quality of life and survival

Speakers: Doctor C. Fauvel, Doctor D. Guarino, Professor C. Kaymaz, Doctor R. Takano, Doctor N. Karia...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources